Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound

Movement Disorders

Volumn 16, Issue 1, 2001, Pages 23-32

  Becker, Georg ^a   Berg, Daniela ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; HEAVY METAL; IRON;

BASAL GANGLION; BIOACCUMULATION; BRAIN ARTERY; BRAIN TISSUE; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; DYSTONIA; ECHOENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYNDROME; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PATHOGENESIS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA;

BASAL GANGLIA DISEASES; BRAIN; DEPRESSION; DYSTONIA; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0035241245     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200101)16:1<23::AID-MDS1003>3.0.CO;2-2     Document Type: Review

References (71)

1. Duguid JR, De La Paz R, DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986;20:744-747.
2. Brooks DJ, Luthert P, Gadian D, Marsden, CD. Does signal-attenuation on high-field T2 weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. J Neurol Neurosurg Psychiatry 1989;52:108-111.
3. Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol Clin 1992;10:405-420.
4. Antonini A, Leenders KL, Meier D, Oertel WH, Boesiniger P, Anliker, M. T2 relaxation time in patients with Parkinson's disease. Neurology 1993;43:697-700.
5. Chen JC, Hardy PA, Kucharczyk W, Clauberg M, Joshi JG, Vourlas A, Dhar M, Henkelman RM. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington Disease. Am J Neuroradiol 1993;14: 275-281.
6. Ye FQ, Allen PS, Martin WR. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord 1996;11:243-249.
7. Brooks DJ, Ibanez V, Sawle GV, et al. Differing patterns of striatal [18F]-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1990;28:547-555.
8. Calne DB, Snow BJ. PET imaging in Parkinsonism. Adv Neurol 1993;60:484-487.
9. Shinotoh H, Hirayama K, Tateno, Y. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET. Adv Neurol 1993;60:488-493.
10. Piccini P, Bum DJ, Ceravolo R, Maraganore D, Brooks DJ. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999;45:577-582.
11. Karbe H, Holthoff VA, Rudolf J, Herholz K, Heiss WD. Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia. Neurology 1992;42:1540-1544.
12. Chase TN, Tamminga CA, Burrows H. Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia. Adv Neurol 1988;50:237-241.
13. Lang AE, Garnett ES, Firnau G, Nahmias C, Talalla A. Positron tomography in dystonia. Adv Neurol 1988;50:249-253.
14. Hierholzer J, Cordes M, Schelosky L, Richter W, Keske U, Venz S, Semmler W, Poewe W, Felix R. Dopamine D2 receptor imaging with Iodine-123-Iodobenzamine SPECT in idiopathic rotational torticollis. J Nucl Med 1994;35:1921-1927.
15. Schöning M, Grunert D, Stier B. Transkranielle Duplexsonographie durch den intakten Knochen: ein neues diagnostisches Verfahren. Ultraschall Med 1989;10:66-71.
16. Furuhata H. New evolution of transcranial tomography (TCT) and transcranial color Doppler tomography (TCDT). Neurosonology 1989;2:8-15.
17. Bogdahn U, Becker G, Winkler J, Greiner K, Perez J, Meurers B. Transcranial color-coded real-time sonography in adults. Stroke 1990;21:1680-1688.
18. Becker G, Griewing B. Examination techniques. In: Bogdahn U, Becker G, Schlachetzki F, eds. Echoenhancers and transcranial color duplex sonography. Berlin: Blackwell; 1998. p 219-231.
19. Puls I, Berg D, Hetzel G, Schliesser M, Becker G. Comparison of B-mode imaging and tissue harmonic imaging. Ultrasound Med Biol 2000;26:189-194.
20. Postert T, Lack B, Kuhn W, Jergas M, Andrich J, Braun B, Przuntek H, Sprengelmeyer R, Agelink M, Buttner T. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry 1999;67:457-462.
21. Becker T, Becker G, Seufert J, et al. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 1997;63:590-596.
22. Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53: 1026-1031.
23. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995;45:182-184.
24. Berg D, Grote C, Rausch WD, Mäurer M, Wesemann W, Riederer P, Becker G. Iron accumulation of the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999;25:901-904.
25. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454.
26. Cummings JL. Behavioral and psychiatric symptoms associated with Huntington's disease. Adv Neurol 1995;65:179-186.
27. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991;50:743-755.
28. Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology 1980;30:1326-1330.
29. Torrack RM, Morris JC. The association of ventral tegmental area histopathology with adult dementia. Arch Neurol 1988;45:497-501.
30. Fibiger HC. The neurobiological substrates of depression in Parkinson's disease. Can J Neurol Sci 1984;11:105-107.
31. Chan-Paley V. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy. Adv Neurol 1993;60:438-446.
32. Chan-Palay V, Asan E. Quantification of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J Comp Neurol 1989;287:373-392.
33. Kienzl E, Eichinger K, Sofic E, Jellinger K, Riederer P, Kuhn W, Fuchs G, Laux G. Urinary dopamine sulfate: regulations and significance in neurological disorders. J Neural Transm Suppl 1990; 32:471-479.
34. Kostic VS, Djuricic BM, Covickovic-Sternic N, Bumbasirevic L, Nikolic M, Mrsulja BB. Depression and Parkinson's disease: possible role of serotonergic mechanisms. J Neurol 1987;234:94-96.
35. Mayeux R, Stern Y, Sano M, Williams JB, Cote L. The relationship of serotonin to depression in Parkinson's disease. Mov Disord 1988;3:237-244.
36. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the interior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.
37. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RJ, Dolan RJ. Depression in Parkinson's disease. A positron emission study. Br J Psychiatry 1994;165:333-339.
38. Becker G, Struck U, Bogdahn U, Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 1994;55:75-84.
39. Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, Bogdahn U, Beckmann H. Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 1995;38:180-184.
40. Carpenter MB, Sutin J. Human Neuroantomy. Baltimore: Williams and Wilkins; 1993. p 403-453, 560-567, 639-642.
41. Geyer MA, Puerto A, Dawsey WJ, Knapp S, Bullard WP, Mandell AJ. Histological and enzymatic studies of the mesolimbic and mesostriatal serotinergic pathways. Brain Res 1976;106:241-256.
42. Thierry AM, Tassin JP, Blanc G, Glowinski J. Studies on mesocortical dopamine systems. Adv Biochem Psychopharmacol 1978;19:205-216.
43. Berg D, Supprian T, Hofmann E, Zeiler B, Jäger A, Lange KW, Reiners K, Becker T, Becker G. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 1999;246:1183-1193.
44. Baumann B, Danos P, Krell D, Diekmann S, Wurthmann C, Bielau H, Bernstein HG, Bogerts B. Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. J Affect Disord 1999;54:217-224.
45. Baumann B, Danos P, Diekmann S, Krell D, Bielau H, Geretsegger C, Wurthmann C, Bernstein HG, Bogerts B. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patients. Eur Arch Psychiatry Clin Neurosci 1999;249:212-9.
46. Baumann B, Danos P, Diekmann S, Bielau H, Gerecke N, Bernstein HG, Bogerts B. Postmortem analysis of noradrenergic and serotonergic brainstem systems in mood disorders. Eur Arch Psychiatry Clin Neurosci 1998;248(Suppl 2):S79.
47. Oyangi K, Takeda S, Takahashi H, Ohama E, Ikuda F. A quantitative investigation of the substantia nigra in Huntington's disease. Ann Neurol 1989;26:13-19.
48. Albin RL, Reiner A, Anderson KD, Penney JB, Young AB. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 1990;27:357-365.
49. Dauer WT, Burke RE, Greene P, Fahn. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 1998;121:547-560.
50. Playford ED, Passingham RE, Marsden CD, Brooks DJ. Increased activation of frontal areas during arm movement in idiopathic torsion dystonia. Mov Disord 1998;13:309-318.
51. Ceballos-Baumann AO, Passinghamn RE, Playford ED, Marsden CD, Brooks DJ. Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann Neurol 1995;37:363-372.
52. Preibisch C, Berg D, Hofmann E, Solymosi L, Naumann M. Cerebral activation patterns in patients with writer's cramp: a functional magnetic resonance imaging study. J Neurol 2000 (in press).
53. Gibb WRG, Lees AJ, Marsden CD. Pathological report of four patients presenting with cranial dystonia. Mov Disord 1988;3:211-221.
54. Hedreen JC, Zweig RM, DeLong MR, Whitehouse PJ, Price DL. Primary dystonia: a review of pathology and suggestions for new directions of study. Adv Neurol 1988;50:123-131.
55. Gibb WR, Kilford L, Marsden CD. Severe generalised dystonia associated with a mosaic pattern gliosis. Mov Disord 1992;3:211-221.
56. Iwata M. MRT pathology of the basal ganglia in dystonic disorders. Adv Neurol 1993;60:535-539.
57. Schneider S, Feifel E, Ott D, Schumacher M, Lücking CH, Deuschl G. Prolonged MRT T2 times of the lentiform nucleus in idiopathic spasmodic torticollis. Neurology 1994; 44:846-850.
58. Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic dystonia. Brain 1985;108:463-483.
59. Lee MS, Rimme JO, Ceballos-Baumann A, Thompson PD, Marsden CD. Dystonia after head trauma. Neurology 1994;44: 1374-1378.
60. Pettigrew LC, Jankovic J. Hemidystonia: a report of 22 patients and a review of literature. J Neurol Neurosurg Psychiatry 1985; 48:650-657.
61. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg 1998;89:713-718.
62. Kumar R, Dagher A, Hutchison WD, Lang AE, Lozano A. Globus pallidus deep brain stimulation for generalized dystonia: clinical and PET investigation. Neurology 1999;11;53:871-874.
63. Becker G, Naumann M, Scheubeck M, Hofmann E, Deimling M, Reiners C, Reiners K. Comparison of transcranial sonography, MRI, and SPECT findings in idiopathic spasmodic torticollis. Mov Disord 1997;12:79-88.
64. Naumann M, Becker G, Toyka KV, Supprian T, Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996;47:1284-1290.
65. Alexander GE, Crutcher MD, DeLong MR. Basal ganglio-thalamocortical circuits: Parallel substrates for motor, occulomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res 1990;85: 119-146.
66. Becker G, Berg D, Rausch WD, Lange KW, Riederer P, Reiners K. Increased tissue copper and manganese content of the lentiform nucleus in primary adult-onset dystonia. Ann Neurol 1999;46:260-263.
67. A receptor-meditated currents in acutely isolated cerebellar Purkinje cells of the rat. Eur J Neurosci 1998;10:522-528.
68. Weiser T, Wienrich M. The effects of copper ions on glutamate receptors in cultured rat cortical neurons. Brain Res 1996;742:211-218.
69. Sadee W, Pfeiffer A, Herz A. Opiate receptors: multiple effects of metal ions. J Neurochem 1982;39:659-667.
70. Berg D, Weishaupt A, Francis MJ, Miura N, Yang X-L, Goodyer ID, Naumann M, Koltzenburg M, Reiners K, Becker G. Changes of copper transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia. Ann Neurol 2000;47:821-830.
71. Kulbisky GP, Rickey DW, Reed MH, Bjorklund N, Gordon R. The axolotl as an animal model for the comparison of 3-D ultrasound with plain film radiography. Ultrasound Med Biol 1999;25:969-975.